Global Drug Trends: Cannabis, Opioids, And The Impact On Societies.pdf

Key Cannabis & Opioid Trends

The United Nations' World Drug Report 2021 offers a comprehensive overview of global drug trends, focusing on cannabis and opioids. Here are the key takeaways:

Cannabis:

Global Use and Potency: Despite decreasing public perception of harm, cannabis use remains widespread, affecting around 275 million people globally (up 22% from 2010). Cannabis potency has nearly quadrupled in some regions, raising concerns about increased health risks, especially for young people.
Regulation: There's a mixed picture globally. While many countries have legalized or decriminalized cannabis for medical or recreational use, others are seeing a rise in synthetic cannabinoids (new psychoactive substances) with unpredictable effects.
Non-Medical Use and Regulation: The report highlights evolving regulatory measures to control non-medical cannabis use, including licensing systems, age restrictions, and public education campaigns.

Opioids:

Deadly Impact: Opioid use disorders remain a major global health crisis, resulting in 18 million years of healthy life lost due mainly to overdose. The COVID-19 pandemic has exacerbated the problem as people struggling with addiction face increased isolation and access to drugs.
Pharmaceutical Opioids: Disparities exist globally in access to pharmaceutical opioids for pain management, with limited availability in low-income regions despite their potential to reduce harmful use of illicit opioids.
Illicit Opioid Supply: The report documents a resurgence of heroin and synthetic opioids like fentanyl, driven by increased production and trafficking, particularly in Asia, Latin America, and parts of Africa.

Other Key Findings:

COVID-19 Impact: The pandemic has led to a surge in online drug sales and contactless transactions, highlighting the need for adaptable strategies to combat drug trafficking while addressing access to treatment during crises.
Stigma and Discrimination: Seven in eight people with drug use disorders receive no treatment due to stigma and discrimination, emphasizing the importance of destigmatizing drug use and improving access to evidence-based care.

Policy Implications:

The report stresses the need for:

Evidence-Based Interventions: Focusing on prevention, treatment, harm reduction, and demand reduction strategies based on robust data.
Access to Controlled Medications: Ensuring equitable access to safe and effective medications for pain management globally.
* International Cooperation: Strengthening international cooperation to combat drug trafficking, address the opioid crisis, and promote human rights-based approaches to drug control.